trichostatin A

Trichostatin is a lipid of Polyketides (PK) class. Trichostatin is associated with abnormalities such as Dentatorubral-Pallidoluysian Atrophy, PARAGANGLIOMAS 3, abnormal fragmented structure, Disintegration (morphologic abnormality) and Hyperostosis, Diffuse Idiopathic Skeletal. The involved functions are known as Acetylation, Cell Differentiation process, histone modification, Gene Silencing and Transcriptional Activation. Trichostatin often locates in CD41a, Hematopoietic System, Chromatin Structure, Blood and Endothelium. The associated genes with Trichostatin are SPI1 gene, CELL Gene, Chromatin, CXCR4 gene and DNMT1 gene. The related lipids are Butyrates, Promega, butyrate, Lipopolysaccharides and Steroids. The related experimental models are Knock-out, Mouse Model, Xenograft Model and Cancer Model.

Cross Reference

Introduction

To understand associated biological information of trichostatin A, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with trichostatin A?

trichostatin A is suspected in Infection, Morphologically altered structure, Ureteral obstruction, Photosensitization, Atherosclerosis, Hypertrophic Cardiomyopathy and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with trichostatin A

MeSH term MeSH ID Detail
Liver Cirrhosis D008103 67 associated lipids
Lung Neoplasms D008175 171 associated lipids
Lupus Vulgaris D008177 1 associated lipids
Lupus Erythematosus, Systemic D008180 43 associated lipids
Lymphatic Metastasis D008207 10 associated lipids
Lymphoma, Follicular D008224 3 associated lipids
Mammary Neoplasms, Experimental D008325 67 associated lipids
Medulloblastoma D008527 22 associated lipids
Melanoma D008545 69 associated lipids
Intellectual Disability D008607 13 associated lipids
Per page 10 20 50 100 | Total 139

PubChem Associated disorders and diseases

What pathways are associated with trichostatin A

Lipid pathways are not clear in current pathway databases. We organized associated pathways with trichostatin A through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with trichostatin A?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with trichostatin A?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with trichostatin A?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with trichostatin A?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with trichostatin A?

Mouse Model

Mouse Model are used in the study 'Regulation of minichromosome maintenance gene family by microRNA-1296 and genistein in prostate cancer.' (Majid S et al., 2010), Mouse Model are used in the study 'Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy.' (Fang MZ et al., 2005) and Mouse Model are used in the study 'Histone deacetylase 3 mediates allergic skin inflammation by regulating expression of MCP1 protein.' (Kim Y et al., 2012).

Xenograft Model

Xenograft Model are used in the study 'Histone deacetylase inhibitors induce growth arrest and differentiation in uveal melanoma.' (Landreville S et al., 2012), Xenograft Model are used in the study 'Extended treatment with physiologic concentrations of dietary phytochemicals results in altered gene expression, reduced growth, and apoptosis of cancer cells.' (Moiseeva EP et al., 2007) and Xenograft Model are used in the study 'Retinoic acid and the histone deacetylase inhibitor trichostatin a inhibit the proliferation of human renal cell carcinoma in a xenograft tumor model.' (Touma SE et al., 2005).

Cancer Model

Cancer Model are used in the study 'Plasma pharmacokinetics and metabolism of the histone deacetylase inhibitor trichostatin a after intraperitoneal administration to mice.' (Sanderson L et al., 2004).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with trichostatin A

Download all related citations
Per page 10 20 50 100 | Total 3126
Authors Title Published Journal PubMed Link
Palazzo A et al. Cell biology: Tubulin acetylation and cell motility. 2003 Nature pmid:12529632
Fernandes I et al. Ligand-dependent nuclear receptor corepressor LCoR functions by histone deacetylase-dependent and -independent mechanisms. 2003 Mol. Cell pmid:12535528
Cheutin T et al. Maintenance of stable heterochromatin domains by dynamic HP1 binding. 2003 Science pmid:12560555
Boutillier AL et al. Selective E2F-dependent gene transcription is controlled by histone deacetylase activity during neuronal apoptosis. 2003 J. Neurochem. pmid:12562525
Tomita K et al. The effect of oxidative stress on histone acetylation and IL-8 release. 2003 Biochem. Biophys. Res. Commun. pmid:12565901
Kim Y et al. Decreased syndecan-2 expression correlates with trichostatin-A induced-morphological changes and reduced tumorigenic activity in colon carcinoma cells. 2003 Oncogene pmid:12584561
Mishra N et al. Histone deacetylase inhibitors modulate renal disease in the MRL-lpr/lpr mouse. 2003 J. Clin. Invest. pmid:12588892
Glaser KB et al. Gene expression profiling of multiple histone deacetylase (HDAC) inhibitors: defining a common gene set produced by HDAC inhibition in T24 and MDA carcinoma cell lines. 2003 Mol. Cancer Ther. pmid:12589032
Kondo Y et al. Critical role of histone methylation in tumor suppressor gene silencing in colorectal cancer. 2003 Mol. Cell. Biol. pmid:12482974
James SY et al. Regulation of retinoic acid receptor beta expression by peroxisome proliferator-activated receptor gamma ligands in cancer cells. 2003 Cancer Res. pmid:12839938
Ding Z et al. Human MI-ER1 alpha and beta function as transcriptional repressors by recruitment of histone deacetylase 1 to their conserved ELM2 domain. 2003 Mol. Cell. Biol. pmid:12482978
Obata T et al. Identification of HRK as a target of epigenetic inactivation in colorectal and gastric cancer. 2003 Clin. Cancer Res. pmid:14695142
Terui T et al. Induction of PIG3 and NOXA through acetylation of p53 at 320 and 373 lysine residues as a mechanism for apoptotic cell death by histone deacetylase inhibitors. 2003 Cancer Res. pmid:14695212
Liu A et al. Oligodendrocyte process outgrowth in vitro is modulated by epigenetic regulation of cytoskeletal severing proteins. 2003 Glia pmid:14603467
Moreira JM et al. The histone deacetylase inhibitor Trichostatin A modulates CD4+ T cell responses. 2003 BMC Cancer pmid:14606959
Remiszewski SW et al. N-hydroxy-3-phenyl-2-propenamides as novel inhibitors of human histone deacetylase with in vivo antitumor activity: discovery of (2E)-N-hydroxy-3-[4-[[(2-hydroxyethyl)[2-(1H-indol-3-yl)ethyl]amino]methyl]phenyl]-2-propenamide (NVP-LAQ824). 2003 J. Med. Chem. pmid:14521422
Noh EJ and Lee JS Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition. 2003 Biochem. Biophys. Res. Commun. pmid:14521905
Condon JC et al. A decline in the levels of progesterone receptor coactivators in the pregnant uterus at term may antagonize progesterone receptor function and contribute to the initiation of parturition. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12886011
Ryu JR and Arnosti DN Functional similarity of Knirps CtBP-dependent and CtBP-independent transcriptional repressor activities. 2003 Nucleic Acids Res. pmid:12888527
Pivot-Pajot C et al. Acetylation-dependent chromatin reorganization by BRDT, a testis-specific bromodomain-containing protein. 2003 Mol. Cell. Biol. pmid:12861021
Grassi G et al. Inhibitors of DNA methylation and histone deacetylation activate cytomegalovirus promoter-controlled reporter gene expression in human glioblastoma cell line U87. 2003 Carcinogenesis pmid:12869421
Ammanamanchi S et al. Acetylated sp3 is a transcriptional activator. 2003 J. Biol. Chem. pmid:12837748
Krämer OH et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. 2003 EMBO J. pmid:12840003
Witt O et al. Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. 2003 Blood pmid:12393499
Yang L et al. An ERG (ets-related gene)-associated histone methyltransferase interacts with histone deacetylases 1/2 and transcription co-repressors mSin3A/B. 2003 Biochem. J. pmid:12398767
Kishikawa S et al. Control elements of Dnmt1 gene are regulated in cell-cycle dependent manner. 2003 Nucleic Acids Res. Suppl. pmid:14510503
Wegener D et al. Improved fluorogenic histone deacetylase assay for high-throughput-screening applications. 2003 Anal. Biochem. pmid:14511685
Kim MS et al. Inhibition of histone deacetylase increases cytotoxicity to anticancer drugs targeting DNA. 2003 Cancer Res. pmid:14612526
Miller TA et al. Histone deacetylase inhibitors. 2003 J. Med. Chem. pmid:14613312
Hitomi T et al. p15(INK4b) in HDAC inhibitor-induced growth arrest. 2003 FEBS Lett. pmid:14623092
Zhang Q et al. Inhibition and reversal of nickel-induced transformation by the histone deacetylase inhibitor trichostatin A. 2003 Toxicol. Appl. Pharmacol. pmid:14575637
Kim JM et al. Changes in histone acetylation during mouse oocyte meiosis. 2003 J. Cell Biol. pmid:12835313
Camarero N et al. Histone deacetylase inhibitors stimulate mitochondrial HMG-CoA synthase gene expression via a promoter proximal Sp1 site. 2003 Nucleic Acids Res. pmid:12626711
Park KK et al. Modulation of Sp1-dependent transcription by a cis-acting E2F element in dhfr promoter. 2003 Biochem. Biophys. Res. Commun. pmid:12788094
Marks J et al. Two functionally divergent p53-responsive elements in the rat bradykinin B2 receptor promoter. 2003 J. Biol. Chem. pmid:12791684
Valls E et al. The SV40 T antigen modulates CBP histone acetyltransferase activity. 2003 Nucleic Acids Res. pmid:12799439
Ferguson M et al. Histone deacetylase inhibition is associated with transcriptional repression of the Hmga2 gene. 2003 Nucleic Acids Res. pmid:12799440
Ji Y et al. A multistep mechanism for the activation of rearrangement in the immune system. 2003 Proc. Natl. Acad. Sci. U.S.A. pmid:12802019
Nemajerová A et al. Trichostatin A suppresses transformation by the v-myb oncogene in BM2 cells. 2003 J. Hematother. Stem Cell Res. pmid:12804181
Park PH et al. Acetylation of histone H3 at lysine 9 by ethanol in rat hepatocytes. 2003 Biochem. Biophys. Res. Commun. pmid:12804592
Kim H et al. The heparan sulfate proteoglycan GPC3 is a potential lung tumor suppressor. 2003 Am. J. Respir. Cell Mol. Biol. pmid:12816733
Hu E et al. Identification of novel isoform-selective inhibitors within class I histone deacetylases. 2003 J. Pharmacol. Exp. Ther. pmid:12975486
Craig JM et al. Centromeric chromatin pliability and memory at a human neocentromere. 2003 EMBO J. pmid:12743043
Enright BP et al. Epigenetic characteristics and development of embryos cloned from donor cells treated by trichostatin A or 5-aza-2'-deoxycytidine. 2003 Biol. Reprod. pmid:12748129
Van Ommeslaeghe K et al. Amide analogues of TSA: synthesis, binding mode analysis and HDAC inhibition. 2003 Bioorg. Med. Chem. Lett. pmid:12749885
Zhao S et al. Requirement of a specific Sp1 site for histone deacetylase-mediated repression of transforming growth factor beta Type II receptor expression in human pancreatic cancer cells. 2003 Cancer Res. pmid:12750289
Schauber J et al. Expression of the cathelicidin LL-37 is modulated by short chain fatty acids in colonocytes: relevance of signalling pathways. 2003 Gut pmid:12692061
Rambhatla L et al. Generation of hepatocyte-like cells from human embryonic stem cells. 2003 Cell Transplant pmid:12693659
Lee SC et al. Activation of terminal B cell differentiation by inhibition of histone deacetylation. 2003 Mol. Immunol. pmid:12695118
Chandler SP et al. Fragile X (CGG)n repeats induce a transcriptional repression in cis upon a linked promoter: evidence for a chromatin mediated effect. 2003 BMC Mol. Biol. pmid:12659659